Skip to Main Content

Paper Details

Benchmarking clinical outcomes and the immunocatabolic phenotype of chronic critical illness after sepsis in surgical intensive care unit patients.
J Trauma Acute Care Surg
76
2018
3-methylhistidine, CCI, IL-10, IL-6, IL-8, Patient, catabolism, chronic critical illness, critically ill, immunosuppression, lymphocyte, patients, plasma insulin-like growth factor binding protein 3, programmed death ligand 1, sepsis
Benchmarking, Chronic Disease, Critical Illness, Female, Follow-Up Studies, Humans, Immune Tolerance, Incidence, Intensive Care Units, Male, Middle Aged, Postoperative Complications, Prognosis, Prospective Studies, Risk Factors, Sepsis, Survival Rate, Time Factors, United States
Author NameAffiliation
Julie A StortzUniversity of Florida College of Medicine Department of Biostatistics (Z.W., University of Florida and Department of Aging and Geriatric Research (C.L.), University of Florida College of Medicine
  • 1 - 1

Datasets

Release 1.2